Last Week in Event SPACE ...
(This insight covers specific insights & comments involving Stubs, Pairs, Arbitrage, share Classification and Events - or SPACE - in the past week)
M&A - ASIA-PAC |
Red Hat Inc (RHT US) (Mkt Cap: $30.6bn; Liquidity: $432mn)
Intl Business Machines (IBM US) announced on October 28th it would acquire Red Hat for $190/share in cash in a $34bn deal, in IBM's largest ever acquisition. The deal price is a 62.8% premium to RHT’s undisturbed price of $116.68, and a 52.7% premium to the average closing price of $124.43 for the month prior to the deal's announcement. Red Hat is trading at a 9% discount to the deal price, creating uncertainty over prospects for the deal’s successful completion.
(link to John's insight: Red Hat/IBM: Does This Red Hat Go with My Big Blue Outfit?)
Don Quijote Holdings (7532 JP) (Mkt Cap: $9.7bn; Liquidity: $47mn)
Familymart Uny Holdings (8028 JP) has launched its Tender Offer to buy 20.17% of retailer Don Quijote, as a way of gaining an equity affiliate stake in the company to which FamilyMart simultaneously agreed to sell the remaining 60% of the UNY GMS business it acquired when it merged with Uny Group Holdings (8270 JP) in 2016. Since the rumour/announcement of the intention to launch the Tender Offer last month, the stock price of Don Quijote has risen from ¥5500 to over ¥7070.
(link to Travis Lundy's insight: FamilyMart Tender for Don Quijote - Elmer vs Mr. Partridge?)
Healthscope Ltd (HSO AU) (Mkt Cap: $2.9bn; Liquidity: $12mn)
Healthscope has received a takeover offer from Brookfield Capital Partners - an Off-Market Takeover Offer of $2.455/share (50.1% acceptance condition), and a simultaneous Scheme representing a total value of $2.585 a share - both inclusive of an interim dividend of A$0.035/share. These proposals, trumping BGH-AustSuper's $2.36/share proposal announced on the 23rd of October, value Healthscope upwards of ~A$4.5bn. Healthscope considers Brookfield's proposal to be attractive and has granted it exclusive due diligence. Healthscope has denied the request for due diligence by BGH.
(link to my insight: Not To Be Outdone, Brookfield Revisits Healthscope)
Unisem (M) (UNI MK) (Mkt Cap: $535mn; Liquidity: $1.8mn)
Three down, one to go. Unisem's Offerors recently secured key PRC approvals (including China’s Gansu Department of Commerce and from the NDRC), which as of when I wrote all but guaranteed the final pre-condition from SAFE. A firm Offer would ensue immediately after receipt. On the 12th of September, Unisem's CEO controlling shareholders and CEO John Chia, together with Tianshui Huatian Technology Co, Ltd. (002185 CH) (TSHT) (the Joint Offerors) announced a pre-conditional takeover at RM3.30/share, an 11.1% premium to last close, in an RM1.82bn deal.
These recent PRC approvals would indicate this Offer is on track to become binding. This also potentially suggests an earlier completion, well ahead of the long-stop date of mid-March under the pre-conditional offer. The gross spread narrowed this week to 3.1%. Tight, but worth getting involved if you can get in a tick or two below.
THE UPDATE: TSHT has now obtained SAFE approval. All the Pre-Conditions have been satisfied.
(link to my insight: Mind The Gap as TSHT Closes In On Unisem)
Propertylink Group (PLG AU) (Mkt Cap: $519mn; Liquidity: $2mn)
Warburg Pincus-controlled ESR Real Estate has launched a $1.20/security cash Offer for Propertylink by way of a Bid Implementation Agreement. There's an intriguing backdrop to this offer - Centuria Capital (CNI AU) pitched an A$0.95/proposal (subsequently rejected) in September last year; followed by an Offer for Centuria Industrial Reit (CIP AU) (in which CNI is the major security holder) by PLG in September of this year, whereupon CNI called into question PLG's business acumen, and requested an EGM to spill PLG's board, which failed to carry this past Thursday.
(link to my insight: ESR Inks Deal With Hunter-And-Hunted Propertylink)
EVENTS |
Toshiba Corp (6502 JP) (Mkt Cap: $22.5bn; Liquidity: $79mn)
Last Monday, Toshiba announced it would conduct a ToSTNeT-3 buyback for all ¥700bn of its share buyback at the prior closing price of ¥3,635/share. That was 192.5722mm shares or roughly 30% of shares outstanding. 33.2286mn shares were bought, leaving Toshiba with ¥579.21bn left to spend. So it announced another ToSTNeT-3 buyback for this residual two days later. The response was even more subdued - 3.9717mn shares. Perhaps it's a case of overestimating the number and size of weak hands here and underestimating the solidarity of those who want to take Toshiba for a ride.
link to Travis' insights:
Toshiba's ToSTNeT-3 Buyback: Unwinding? Another Game of 🐓?
Toshiba ToSTNeT-3: Round 2 (¥579bn To Go)
Hanjin Kal Corp (180640 KS) (Mkt Cap: $1.5bn; Liquidity: $15mn)
Hanjin is the target of corporate activism after Grace Holdings Ltd, a subsidiary of Korea Corporate Governance Improvement (KCGI), acquired a 9% stake (5.32m shares). KCGI's corporate activism on Hanjin Kal is the third major case of corporate activism in Korea in 2018, following Elliott Management vs. the Hyundai Motor Group (Elliott Mgmt Goes "Activist" On the Hyundai Motor Group) and Platform Partners vs. MKIF (Platform Partners Goes Activist on Macquarie Korea Infrastructure Fund (MKIF)).
(link to Douglas' insight: KCGI Goes Activist on Hanjin Kal Corp & Our NAV Analysis of Hanjin Kal)
Samsung Electronics (005930 KS) (Mkt Cap: $15.3bn; Liquidity: $408mn)
Sanghyun Park flagged that the common/pref price ratio now stands at 1.19246 compared to the one-year average of 1.22732, and recommends a long common/short pref trade, and would close the position when the price ratio gets reduced by 2.5~3%p.
(link to Sanghyun's insight: Samsung Electronics Share Class Trade: Initiate Long Common/Short Pref Position)
Hyundai Motor Co (005380 KS) (Mkt Cap: $18.2bn; Liquidity: $51mn)
Elliott ratcheted up the pressure on Hyundai Motor Group earlier this week, urging it to return $10.6bn of capital to shareholders and consider selling non-core assets.
(link to Sanghyun's insight: Hyundai Motor Share Class Trade: Long Pref 1 / Short Pref 2 with Elliott's Latest Action)
SK Securities (001510 KS) (Mkt Cap: $225mn; Liquidity: $1.9mn)
SK Securities subscription rights are now trading, and will run for 5 trading days until Nov 22. Preliminary pricing was done on Oct 25, and it was priced at ₩564, and will likely serve as a price ceiling for the offer. As of now, subscription rights are trading at ₩144. Preliminary price is ₩564, and the current stock price is at ₩740. The spread stands at 4.8%.
(link to Sanghyun's insight: SK Securities Rights Offer: Arb Trading Status)
M&A - EUROPE |
Ceva Inc (CEVA US) (Mkt Cap: $1.6bn; Liquidity: $13mn)
After CEVA rejected unsolicited, non-binding offers from Danish freight-forwarding group DSV A/S (DSV DC) of CHF 27.75/share and CHF 30/share, CMA CGM SA (144898Z FP) has (reluctantly?) stepped in and entered into a new relationship agreement with CEVA, such that CMA CGM will transfer its freight management activities to CEVA Logistics (subject to anti-trust approval). CMA CGM announced a voluntary public tender offer at CHF 30/share - despite earlier being on record it had no plans to launch a full takeover.
Given earnings uncertainty, investors can opt for the short-term guarantee and take the CHF 30/share. There is no minimum condition attached to this public offer. CMA will formally publish its offer via a “pre-announcement” to be made by 30 November at the latest. The cash consideration is expected 1Q19/early 2Q19.
(link to my insight: CEVA's Days Of Independence Appear Numbered)
STUBS/HOLDCOS |
Samsung C&T (028260 KS) (Mkt Cap: $15.3bn; Liquidity: $44mn)
The Samsung C&T holdco discount remains at a historic low despite Samsung Biologics Co., (207940 KS)'s recent misfortune. BioLogics' accounting fraud issue is still ongoing. But Sanghyun thinks BioLogics shares fully reflect the negative news. The FSS will likely give a pretty harsh punitive measure to BioLogics, but he doesn't really expect it to go as far as delisting.
Sanghyun would initiate a setup trade, and short Samsung Electronics (005930 KS), which has risen nearly 10% over the last two weeks. As the SamE common-pref price ratio is also out of sync, one alternative is to short SamE pref for a hedge on my C&T stub trade.
THE UPDATE: The FSC said it has found intentionality behind BioLogics’ breach of accounting rules. Therefore, the FSC has pressed criminal charges against BioLogics management, a move that immediately suspends BioLogics from trading. Sanghyun believes delisting won't happen. The government wanted to send a clear message that they wouldn't be easy on a case like this. But they must be also very well aware that too much is at stake if they delist the country's fifth largest stock.
links to Sanghyun's insights:
Samsung C&T Stub Trade: Holdco Discount Still at a Historic Low Despite BioLogics Misfortune
Samsung BioLogics Trade Suspension: Short Celltrion/Long Samsung C&T
OTHER M&A UPDATES |
CCASS |
My ongoing series flags large moves (~10%) in CCASS holdings over the past week or so, moves which are often outside normal market transactions. These may be indicative of share pledges. Or potential takeovers. Or simply help understand volume swings.
Often these moves can easily be explained - the placement of new shares, rights issue, movements subsequent to a takeover, amongst others. For those mentioned below, I could not find an obvious reason for the CCASS move.
Name | % change | Into | Out of | Comment |
Glorious Property (845 HK) | 18.98% | Haitong | HSBC | |
China Environmental Technology (646 HK) | 10.37% | Eternal Pearl | Sunfood | |
Shirble Department Stores (312 HK) | 62.88% | UBS | Outside CCASS | |
Shen You Holdings Ltd (8377 HK) | 50.00% | Upbest | Huabang | |
MS Concept Ltd (8447 HK) | 24.00% | Chaoshang | Outside CCASS |
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.